Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

124.00SEK
11:12am EDT
Change (% chg)

0.00kr (+0.00%)
Prev Close
124.00kr
Open
123.70kr
Day's High
124.20kr
Day's Low
122.65kr
Volume
480,801
Avg. Vol
1,379,673
52-wk High
124.20kr
52-wk Low
66.12kr

Chart for

About

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer... (more)

Overall

Beta: 0.99
Market Cap(Mil.): kr44,986.12
Shares Outstanding(Mil.): 368.59
Dividend: 0.70
Yield (%): 0.97

Financials

  EKTAb.ST Industry Sector
P/E (TTM): 43.14 37.52 33.34
EPS (TTM): 2.87 -- --
ROI: 8.37 8.76 13.18
ROE: 14.89 12.58 15.09

UPDATE 1-Elekta Q4 adjusted operating profit below forecasts, dividend higher

June 1 Swedish radiation therapy equipment maker Elekta on Friday reported below-forecast earnings for its fiscal fourth quarter, but proposed a higher dividend than expected.

Jun 01 2018

BRIEF-Apollo Hospitals Group chooses Elekta for new proton center

* APOLLO HOSPITALS GROUP CHOOSES ELEKTA'S MOSAIQ FOR NEW PROTON CENTER Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

May 04 2018

BRIEF-Elekta Makes Strategic Investment In PalabraApps

* ELEKTA EXPANDS THE MOSAIQ ECOSYSTEM OF COMPLEMENTARY APPLICATIONS WITH STRATEGIC INVESTMENT IN PALABRAAPPS

Apr 12 2018

BRIEF-Elekta wins government tender in Mexico

* ELEKTA STRENGTHENS PRESENCE IN MEXICO WITH GOVERNMENT TENDER FOR RADIATION THERAPY TECHNOLOGY

Apr 09 2018

BRIEF-Elekta has won order in ‍Egypt, was booked in Q3 ​

* SAYS EGYPT HAS AGAIN CHOSEN ELEKTA tO EQUIP ITS MINISTRY OF HEALTH HOSPITALS, INCLUDING NATIONAL CANCER INSTITUTE (NCI) IN CAIRO​

Apr 06 2018

UPDATE 2-Elekta shares jump on forecast-beating Q3 earnings

March 2 Swedish radiation therapy equipment maker Elekta on Friday reported above-forecast earnings and order intake for its fiscal third quarter, sending shares higher and outweighing a cut margin forecast for the full year.

Mar 02 2018

BRIEF-Elekta AB Q3 profit and orders top forecasts, cuts full-year margin target

* Q3 ‍GROSS ORDER INTAKE AMOUNTED TO SEK 3,833 M (3,653), AN INCREASE OF 9 PERCENT BASED ON CONSTANT EXCHANGE RATES AND 5 PERCENT IN SEK​

Mar 02 2018

BRIEF-Bolivia buys linear accelerators from Elekta

* BOLIVIAN GOVERNMENT INVESTS IN STATE-OF-THE-ART CANCER CARE FROM ELEKTA

Feb 21 2018

BRIEF-Elekta's Gamma Knife system cleared for use by China

* ELEKTA'S LEKSELL GAMMA KNIFE ICON RADIOSURGERY SYSTEM CLEARED FOR USE IN CHINA Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Feb 05 2018

BRIEF-Elekta signs $29 mln deal with the Ottawa Hospital

* THE OTTAWA HOSPITAL ACQUIRES SEVERAL ELEKTA VERSA HD DEVICES FOR ADVANCED CANCER TREATMENT

Jan 31 2018

Earnings vs. Estimates